Literature DB >> 2254472

Toxic epidermal necrolysis after bone marrow transplantation: study of nine cases.

G Villada1, J C Roujeau, C Cordonnier, M Bagot, M Kuentz, J Wechsler, J P Vernant.   

Abstract

Acute graft-versus-host reaction after allogeneic bone marrow transplantation has been reported to induce toxic epidermal necrolysis. To assess the respective role of acute graft-versus-host disease and of drug reaction in this setting, we retrospectively reviewed nine cases of toxic epidermal necrolysis that occurred in a series of 152 allogenic bone marrow recipients. In five cases visceral involvement was suggestive of acute graft-versus-host disease without any drug more than "doubtfully" suspected. In four cases extracutaneous symptoms were absent or mild and suspect drugs (mainly sulfonamides) had been administered with a timing suggestive of "possible" causality. All nine patients died, mainly from infection possibly aggravated by high doses of corticosteroids. We conclude that toxic epidermal necrolysis may be more frequent than generally thought after bone marrow transplantation and has a poor prognosis. It seems to be related to a drug reaction to sulfonamides as often as to acute graft-versus-host disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2254472     DOI: 10.1016/0190-9622(90)70307-4

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  11 in total

1.  New insights in toxic epidermal necrolysis (Lyell's syndrome): clinical considerations, pathobiology and targeted treatments revisited.

Authors:  Philippe Paquet; Gérald E Piérard
Journal:  Drug Saf       Date:  2010-03-01       Impact factor: 5.606

2.  Toxic Epidermal Necrolysis in Recessive Dystrophic Epidermolysis Bullosa following Bone Marrow Transplantation.

Authors:  Christina L Boull; Sara A Hylwa; Dusan Sajic; John E Wagner; Jakub Tolar; Kristen P Hook
Journal:  J Pediatr       Date:  2016-03-11       Impact factor: 4.406

Review 3.  Drug-induced severe skin reactions. Incidence, management and prevention.

Authors:  P Wolkenstein; J Revuz
Journal:  Drug Saf       Date:  1995-07       Impact factor: 5.606

Review 4.  Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  Steven J Parrillo
Journal:  Curr Allergy Asthma Rep       Date:  2007-07       Impact factor: 4.919

Review 5.  Allergic emergencies encountered by the dermatologist. Severe cutaneous adverse drug reactions.

Authors:  P Wolkenstein; J Revuz
Journal:  Clin Rev Allergy Immunol       Date:  1999       Impact factor: 10.817

6.  A rare case of toxic epidermal necrolysis with unexpected Fever resulting from dengue virus.

Authors:  Gerrit Grieb; Mastoura Alazemi; Rituparna Das; Sebastian E Dunda; Paul C Fuchs; Norbert Pallua
Journal:  Case Rep Dermatol       Date:  2010-12-07

Review 7.  Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

Authors:  Marianne Lerch; Carlo Mainetti; Benedetta Terziroli Beretta-Piccoli; Thomas Harr
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 10.817

8.  Toxic Epidermal Necrolysis and Graft-versus-Host Reaction: Revisiting a Puzzling Similarity.

Authors:  G E Piérard; T Hermanns-Lê; P Paquet; A F Rousseau; P Delvenne; C Piérard-Franchimont
Journal:  ISRN Dermatol       Date:  2013-06-03

Review 9.  Toxic epidermal necrolysis: a paradigm of critical illness.

Authors:  Alfonso Estrella-Alonso; José Antonio Aramburu; Mercedes Yolanda González-Ruiz; Lucía Cachafeiro; Manuel Sánchez Sánchez; José A Lorente
Journal:  Rev Bras Ter Intensiva       Date:  2017 Oct-Dec

Review 10.  Interventions for toxic epidermal necrolysis.

Authors:  S Majumdar; M Mockenhaupt; J- Roujeau; A Townshend
Journal:  Cochrane Database Syst Rev       Date:  2002
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.